TAMMY SADIGHI: Open Payments
NPI 1972733277 · FORT MYERS, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$897 in 8 payments from 7 companies in 2025. Trend: 2023 $852 · 2024 $948 · 2025 $897
Food & beverage: $897
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $250 |
| Astellas Pharma US Inc | 1 | $140 |
| Neurocrine BioSciences, Inc. | 1 | $137 |
| Novo Nordisk Inc | 1 | $120 |
| PFIZER INC. | 1 | $100 |
| Boston Scientific Corporation | 1 | $89 |
| SANOFI-AVENTIS U.S. LLC | 1 | $62 |
Products named: CAPLYTA, Veozah, INGREZZA, Ozempic, COMIRNATY, Axonics, TZIELD.
Industry payments across FL — which companies pay providers there.
